Advanced Search

column
PDA-mediated Mild Photothermal Therapy Combined with Autophagy Inhibitors Kill Breast Cancer Cells
LIU Yawen, LU Jiahui, NI Chen, HUANG Jie, HUANG Tianhao, SHEN Nan, DONG Yulin, SHI Meilin, HU Junfeng
2021, 48(7): 659-666. DOI: 10.3971/j.issn.1000-8578.2021.21.0142
Abstract PDF
Endogenous HMGB1 Modulates Fatty Acid Metabolism of Hypoxic and Nutrient-poor Pancreatic Cancer Cells and Related Mechanism
GAO Jie, WU Qiwei, SONG Lian, SHI Hui, WANG Ming, GONG Aihua, WANG Dongqing, ZHU Haitao
2021, 48(7): 667-673. DOI: 10.3971/j.issn.1000-8578.2021.21.0038
Abstract PDF
Panx1 Promotes Cisplatin-induced Apoptosis of A549 Cells by Regulating ATP/IP3 Pathway
LONG Wenqing, ZHANG Huili, XIE Haijuan, WANG Yuxing, ZHANG Lijun, YU Hongnyu, WANG Lin
2021, 48(7): 674-678. DOI: 10.3971/j.issn.1000-8578.2021.20.1546
Abstract PDF
Expression of MPZL1 in Gastric Cancer and Its Effect on Proliferation of Tumor Cells
LIN Fengjuan, GE Xiaoxiao, WU Zheng, TANG Wenbo, LIN Ying, LI Jin
2021, 48(7): 679-685. DOI: 10.3971/j.issn.1000-8578.2021.20.1458
Abstract PDF
miR-325-3p Regulates Epithelial-mesenchymal Transition, Invasion and Metastasis of Gastric Cancer via Targeting CLDN1 Gene
DU Jitao, CAO Jian, ZHAO Wen, WAN Xiangbin, LI Zhi
2021, 48(7): 686-693. DOI: 10.3971/j.issn.1000-8578.2021.20.1200
Abstract PDF
Effect of SABP, A Water-soluble Component of Salvia Miltiorrhiza, on Immune Microenvironment of Mice with Liver Cancer
LI Shenghao, HAO Liyuan, GUO Yinglin, PENG Qing, DING Jingru, SHI Xinli
2021, 48(7): 694-698. DOI: 10.3971/j.issn.1000-8578.2021.20.1405
Abstract PDF
Expression of JMJD2B and HIF-1α in Rhabdomyosarcoma Tissues and Their Prognostic Significance
WU Hongzeng, ZHAO Jiazheng, ZHAO Yi, MA Xiaowei, FENG Helin
2021, 48(7): 699-703. DOI: 10.3971/j.issn.1000-8578.2021.21.0030
Abstract PDF
Value of DNA Repair Gene and TP53 Co-mutation in Predicting Effect of Immunotherapy on Lung Adenocarcinoma
CHEN Guangying, MA Junxun, HU Yi
2021, 48(7): 704-708. DOI: 10.3971/j.issn.1000-8578.2021.20.1438
Abstract PDF
Effect of miR-7-5p on Proliferation, Invasion of Non-small Cell Lung Cancer Cells by Targeting POLE4 and Its Underlying Mechanism
WANG Fuxia, YAO Feifei, LI Zengyan
2021, 48(7): 709-713. DOI: 10.3971/j.issn.1000-8578.2021.20.1275
Abstract PDF
Prognosis of Stage ⅠB-ⅡA Cervical Squamous Cell Carcinoma Patients with Intermediate Risk Factors Treated with Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy: A Prospective Randomized Controlled Trial
PAN Zhongmian, CHEN Qi, LI Li
2021, 48(7): 714-718. DOI: 10.3971/j.issn.1000-8578.2021.20.0905
Abstract PDF
Clinical Efficacy of Anlotinib Combined with Paclitaxel and Cisplatin as First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
YANG Xiaoli, WANG Cailing, XIA Jin, WANG Junsheng
2021, 48(7): 719-722. DOI: 10.3971/j.issn.1000-8578.2021.21.0095
Abstract PDF
Therapeutic Effect of Apatinib in First-line Treatment of Advanced Liver Cancer
KE Shaobo, WANG Jing, QIU Hu, CAI Gaoke, GONG Yi, CHEN Yongshun
2021, 48(7): 723-726. DOI: 10.3971/j.issn.1000-8578.2021.20.1161
Abstract PDF
Trends of Pancreatic Cancer Incidence and Mortality in Changning District of Shanghai
FANG Jie, WANG Jie, LI Honglan, FENG Guoshan, WU Hua, JIANG Yufei, JIANG Yu, ZHANG Lei, ZHANG Yun, ZHOU Peng, XIA Qinghua, ZHAO Wensui, XIANG Yongbing
2021, 48(7): 727-732. DOI: 10.3971/j.issn.1000-8578.2021.20.1116
Abstract PDF
Risk of Primary Lung Cancer in Breast Cancer Patients: A Systematic Review and Meta-analysis
LIU Jinzhao, ZHANG Xiangmei, ZHOU Yarong, LIU Yunjiang
2021, 48(7): 733-737. DOI: 10.3971/j.issn.1000-8578.2021.20.1430
Abstract PDF
Research Progress on Animal Model for Cancer-related Fatigue
JIN Ming, XIE Lulu, MAO Ni, SHEN Xubo, WEI Jianzi, SHEN Xueyong, MAO Huijuan
2021, 48(7): 738-742. DOI: 10.3971/j.issn.1000-8578.2021.21.0092
Abstract PDF
New Potential Target for Cancer Immunotherapy Discovered by Renmin Hospital of Wuhan University, etc
2021, 48(7): 743-743. DOI: 10.3971/j.issn.1000-8578.2021.07.0001
Abstract PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：